Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System

NCT: NCT05686317 · ACTIVE_NOT_RECRUITING

NCT IDNCT05686317
StatusACTIVE_NOT_RECRUITING
Start Date2023-04-01
Completion2030-08-31
SponsorEdwards Lifesciences (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, multi-center, randomized, sham-controlled, double-blinded (participant and outcomes assessor) clinical trial.

Frequently Asked Questions

What is ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System?

ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System is a clinical trial registered under NCT05686317. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05686317?

The current status of NCT05686317 (ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System) is: ACTIVE_NOT_RECRUITING.

When did ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System start?

ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System started on 2023-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑